Meurice R&D
Meurice R&D, founded in 1994, partners with Belgian and international companies in chemistry, biochemistry, brewing, fermentation, food technology, bioprocesses, and protein purification.
BioWin members represent a wide range of biopharma and health-tech industrial and academic organisations including research labs, big pharma, SMEs, universities, hospitals operating across Wallonia.
Meurice R&D, founded in 1994, partners with Belgian and international companies in chemistry, biochemistry, brewing, fermentation, food technology, bioprocesses, and protein purification.
Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy.
Minoryx Therapeutics is a private VC-backed company developing innovative therapies for the treatment of orphan CNS (central nervous system) diseases.
Multitel is a research and innovation centre that offers services to companies and develops new technological concepts in the following fields:
My Engineering is a Belgian company specializing in industrial project management, offering audit, design, construction management, and validation services with flexibility, expertise, and quality.
Become a BioWin member today!
MyCellHub provides a cloud-based bio-manufacturing execution system for GMP compliance, digitalizing workflows like batch records, cleaning, and environmental monitoring in cell and gene therapy production
NARILIS advances life sciences research to improve health by studying diseases, diagnosis, treatment, and prevention across all biological levels.
Natix brings together a group of companies with a common vision
neuroClues develops an eye-tracking solution for early detection of neurological diseases by analyzing eye movements to identify specific biomarkers
Neuvasq develops therapeutics to restore neurovascular function, including NVQ042 for vascular retinopathies and NVQ061 to target neurodegenerative diseases like Alzheimer’s, Parkinson’s, multiple sclerosis, and epilepsy.
Novadip develops regenerative therapies for critical bone defects, utilizing adipose-derived stem cells to accelerate healing in conditions like bone non-union and spinal fusion.
Nucleis, a University of Liège spin-off, manufactures and distributes PET radiopharmaceuticals for diagnostics and therapy monitoring, supporting innovative therapies.
Nyxoah develops medical technology for obstructive sleep apnea, focusing on the Genio® system, a hypoglossal nerve stimulation therapy for treating moderate to severe cases.
Oncodesign Precision Medicine is a biopharmaceutical company specializing in precision medicine to treat resistant and metastatic cancers.
OncoDNA is a theranostic and genomic company specialising in precision oncology.
Op2Lysis develops innovative thrombolytic therapies, using NANOp2Lysis® technology and OptPA to dissolve brain hematomas and blood clots, aiming to treat stroke and intracerebral hemorrhage.
O+R designs and builds cleanrooms with expertise in mechanics, electrical systems, automation, airflow, and hydraulics.
Osivax is a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating infectious viruses.
OUAT! partners with life sciences companies, offering HakoBio, a web platform enabling biopharmaceutical firms to create 3D digital twins of their factories easily.
A Biotechnology company that develops a new class of potent and off-the-shelf therapeutic cancer vaccines based on a proprietary cell line of Plasmacytoid Dendritic Cells
Pharmaplan, part of TTP Group, is a leading European engineering company specializing in GMP-regulated industries, offering comprehensive services from design to validation.
PHÉNX, founded in 2016, provides engineering services for the Life Science Industry, focusing on project management, commissioning, and validation from concept to final handover.